Safe Baby Formula Act of 2026
To require the Secretary of Health and Human Services to conduct a study on the impacts of arsenic, cadmium, mercury, and lead in infant formula on infant health and establish standards for regulating the content of such substances in infant formula.
HB9949, known as the Safe Baby Formula Act of 2026, aims to ensure the safety of infant formula by studying the health impacts of harmful substances such as arsenic, cadmium, mercury, and lead. The bill requires the Secretary of Health and Human Services to conduct a comprehensive study on these substances in infant formula and establish standards to regulate their levels. This will help protect infants from potential health risks associated with these contaminants.
This bill would primarily affect parents, caregivers, and manufacturers of infant formula. By setting regulatory standards, it would ensure that infant formula on the market is safer for babies to consume. Manufacturers would need to comply with new standards to ensure their products meet safety requirements, potentially leading to changes in production processes and ingredient sourcing.
As of July 27, 2026, HB9949 was introduced in the House and referred to the House Committee on Energy and Commerce. This means the bill is in the early stages of the legislative process, where it will be reviewed and possibly revised before any further action is taken.
